Artwork for podcast PeDRA Pearls
Points of Discussion: Should JAK Inhibitors be Considered for First-Line Therapy in the Treatment of AD in Children? Episode 2
31st January 2022 • PeDRA Pearls • Pediatric Dermatology Research Alliance
00:00:00 00:31:06

Share Episode

Shownotes

JAK Inhibitors versus Biologics

The group weighs the pros and cons of these treatments options and discusses whether or not they would use them together in severe cases of atopic dermatitis in children. They also highlight the importance of considering overall patient emotional and mental health when looking at these different treatment options.  

Links